CURRICULUM VITAE
Name: James M. Ellison, M.D., M.P.H. Date Prepared: 04/04/17
Clinical office: Swank Memory Care Center 501 West 14th Street Gateway Building, 5th Floor Wilmington, Delaware 19801 (302) 320-2637 / Fax (302) 320-2638
Administrative office: Same as above
Additional clinical office: 90 Concord Avenue, Belmont, MA 02478 (617) 489-7375 / Fax: (617) 489-8068
Home Address: 902 N. Market Street, Apartment 1005 Wilmington, DE 19801 (617) 233-8623
Place of Birth: Minneapolis, Minnesota
Education:
06/1974 BA Harvard College, Cambridge, MA 06/1978 MD University of California School of Medicine, San Francisco, CA 06/1993 MPH Harvard School of Public Health, Boston, MA
Postdoctoral Training:
Internships and Residencies:
07/1978-06/1979 Rotating Internship, Massachusetts General and Waltham Hospitals, Boston and Waltham, MA 07/1979-06/1981 Resident in Psychiatry, Mass. General Hospital, Boston, MA 07/1981-06/1982 Chief Resident, Acute Psychiatry Service, Massachusetts General Hospital, Boston, MA
Additional Studies:
07/1991-06/1993 Harvard School of Public Health, Masters Program
Licensure and Certification:
1979 National Board of Medical Examiners 1980 Massachusetts Medical License, Number 44908 1984 American Board of Psychiatry and Neurology Certificate 26310 1996 American Board of Psychiatry and Neurology: Added Qualifications in Geriatric Psychiatry Certificate 1821 1998 Certification in Psychopharmacology by ASCP 2007 Recertification for Added Qualifications in Geriatric Psychiatry Certificate 1821 2015 Delaware Medical License, Number C1-0011443
Academic Appointments:
1982-1984 Assistant Professor of Psychiatry, Tufts University School of Medicine 1984-1992 Lecturer in Psychiatry, Tufts University School of Medicine 1984-1985 Lecturer in Psychiatry, Harvard Medical School 1985-1994 Assistant Professor in Psychiatry, Harvard Medical School 1992-1993 Associate Professor in Psychiatry, Tufts University School of Medicine 1994-2013 Lecturer in Psychiatry, Tufts University School of Medicine 1994-1995 Assistant Clinical Professor of Psychiatry, Harvard Medical School 1995-2003 Associate Clinical Professor of Psychiatry, Harvard Medical School 2003-2015 Associate Professor of Psychiatry, Harvard Medical School 2016- Professor of Psychiatry and Human Behavior (Clinical and Educational Scholarship Track), Sidney Kimmel Medical College of Thomas Jefferson University
Hospital Appointments:
1982-1984 Staff Psychiatrist, New England Medical Center, Boston, MA 1984-1990 Staff Psychiatrist, The Cambridge Hospital, Cambridge, MA 1990-2001 Courtesy Staff, The Cambridge Hospital, Cambridge, MA 1984-1994; 1996-2008 Consultant Staff, Mount Auburn Hospital, Cambridge, MA 1987-1990 Staff Psychiatrist, Metropolitan State Hospital, Waltham, MA 1990-1991 Staff Psychiatrist, Heritage Hospital, Somerville, MA 1990-1991 Staff Psychiatrist, Winthrop Hospital, Winthrop, MA 1996- Consultant Staff, The Austen Riggs Center, Stockbridge, MA 1997-1998 Courtesy Staff, Winchester Hospital, Winchester, MA 1993-1998 Chief Psychiatrist, Harvard Community Health Plan, then Harvard Pilgrim Health Care, then Harvard Vanguard Medical Associates, Burlington, MA 06/1998-02/1999 Chief of Psychiatry and Medical Director, Psychiatric Services, Boston Regional Medical Center, Stoneham, MA 02/1999-01/2000 Assistant Psychiatrist, McLean Hospital 01/2000-08/2015 Associate Psychiatrist, McLean Hospital 09/2016- Swank Foundation Endowed Chair in Memory Care and Geriatrics
Principal Clinical and Administrative Service Responsibilities:
1981-1983 Student Mental Health Consultation, Boston Conservatory of Music, Boston 1982-1984 Liaison between Psychiatry Department and Student Health Service, New England Medical Center 1982-1984 Medical Student Faculty Advisor, Tufts University 1982-1984 Assistant Residency Training Director in Psychiatry, New England Medical Center 1982-1984 Founder and Director, Emergency Psychiatry Service, New England Medical Center 1984-1986 Psychiatric Consultant, North Cambridge and Somerville Mental Health Centers 1984-1990 Founder and Director, Somatic Therapies Service, Department of Psychiatry, The Cambridge Hospital 1984-1994 Psychiatric Consultant, Mt. Auburn Hospital 1987-1990 Director of Psychopharmacology Consultation, Metropolitan State Hospital, Waltham, MA 1987-1990 Founder and director of ECT Services, The Cambridge Hospital 1990-1991 Chief of Psychiatry, Heritage Hospital 1990-1991 Medical Director, Outpatient Addictions Program, Heritage Hospital 1990-1991 Medical Director, Psychiatric Services, Heritage Hospital 1991 Interim Chief of Psychiatry, Winthrop Hospital, Winthrop, MA 1992-1993 Director of Clinical Psychopharmacology, New England Medical Center (Adult Division) 1993 Director, Psychiatric Emergency Service, New England Medical Center 1993 Director, Mood and Anxiety Disorders Module, New England Medical Center 1993-1998 Chief, Mental Health Service, Harvard Community Health Plan, Burlington Center, Burlington, MA (now Harvard Pilgrim Health Care) 1998-1999 Attending psychiatrist and Clinical Director, Adult Inpatient Service, Boston Regional Medical Center, Stoneham, MA 1998-1999 Attending psychiatrist, Geriatric Inpatient Service, Boston Regional Medical Center Stoneham, MA 02/1999-04/1999 Program Consultant to Medical Director (Geriatric Service), McLean Hospital, Belmont, MA 04/1999-01/2000 Interim Clinical Director, Geriatric Psychiatry Service, McLean Hospital, Belmont, MA 01/2000-06/2012 Clinical Director, Geriatric Psychiatry Service, McLean Hospital, Belmont, MA 01/2000-01/2001 Director, Ambulatory Service, McLean Hospital, Belmont, MA 01/2001-06/2003 Medical Director, Geriatric Partial Hospital Program, McLean Hospital, Belmont, MA 06/2003-08/2015 Director, Memory Disorders Clinic, McLean Hospital, Belmont, MA 05/2009-08/2015 Program Director, Partners HealthCare Geriatric Psychiatry Fellowship, Boston, MA 06/2012-08/2015 Director, Geriatric Psychiatry Program, McLean Hospital, Belmont, MA 09/2015- Swank Foundation Endowed Chair in Memory Care and Geriatrics, Christiana Care Health System, Wilmington, DE
Committee Assignments:
Tufts School of Medicine: 1982-1984 Residency Training Coordinators Committee, Psychiatry, TUSM, member
Various Hospitals: 1980-1982 Psychiatry Grand Rounds Committee, MGH, member 1982-1984 Emergency Care Committee, New England Medical Center, member 1983-1984 Psychiatry Grand Rounds Committee, NEMC, member 1985-1987 Appointments and Promotions Committee, The Cambridge Hospital, member 1986-1988 Executive Council, Psychiatry Faculty Organization, The Cambridge Hospital, member 1987-1988 Morbidity and Mortality Committee, The Cambridge Hospital, member 1988-1990 Institutional Review Board, The Cambridge Hospital, chairperson 1989-1990 Faculty Review Committee, The Cambridge Hospital, member 1991 Quality Assurance Committee, Heritage Hospital, member 1991 Utilization Review Committee, Heritage Hospital, chairperson 1991 Safety Committee, Heritage Hospital, member 1991 Pharmacy and Therapeutics Committee, Heritage Hospital, member 1991 Executive Committee, Heritage Hospital, member 1991 Medical Records Committee, Heritage Hospital, member
Harvard Pilgrim Health Care: 1994-1998 Mental Health Chiefs Committee, member 1994 Medicare Task Force Committee, member 1995 Task Force on High Utilizers, member 1995-1998 Burlington Center, Pharmacy and Therapeutics Committee, member 1995-1998 Research Committee, member 1995-1998 Psychopharmacology Committee, member
Boston Regional Medical Center 1998-1999 Ethics Committee, member 1998-1999 Medical Records Committee, member
McLean Hospital 1999-2015 General Executive Committee, member 2000-2015 Patient Care Assessment Committee Executive Committee, member 2000-2015 Joint Conference Committee, Administrative representative 2003-2015 Pharmacy and Therapeutics Committee 2010-2015 McLean Academic Steering Committee
Professional Society Involvement: 1979- American Medical Association, member 1981- American Psychiatric Association, member 1981-2015 Massachusetts Psychiatric Society, member 1984-1986 MPS Programs Committee, member 1991-1992 MPS Inpatient Psychiatry Committee, member 1994 MPS Nominating Committee, member 1997-1998 MPS Task Force on Psychopharmacology Management Standards, chairperson 1999-2000 MPS Task Force on Medical Clearance, member 1987-2005 Group for Advancement of Psychiatry, member 1991-2004 The Association for Convulsive Therapy, member 1991 American Society for Addiction Medicine, member 1993- American Society of Clinical Psychopharmacology, member 1997- ASCP Curriculum Committee, member 1997-1998 Task Force on Psychiatrists in Consultative, Collaborative, and Supervisory Relationships (Harvard Risk Management Foundation), co-chair 2000- American Association for Geriatric Psychiatry, member 2000-2002 Secretary, Massachusetts Psychiatric Society 2002-2003 President Elect, Massachusetts Psychiatric Society 2002-2015 Geriatric Interest Group, Massachusetts Psychiatric Society 2002- Associate Member, International College of Geriatric Psychoneuropharmacology 2002 International Psychopharmacology Algorithm Project, Member of Depression Committee 2002-2003 Consultant for Local Arrangements to the Scientific Program Committee of the Institute on Psychiatric Services (APA) 2002-2006 American Association of Community Psychiatrists, member 2003-2004 President, Massachusetts Psychiatric Society 2007-2009 Member, Nominating Committee, AAGP 2015- Member, Massachusetts Medical Society Committee on Senior Physicians 2015- Member, Psychiatric Society of Delaware 2016- Councilor, Psychiatric Society of Delaware 2016- APA representative to AMA Work Group on Assessment of Senior/Late Career Physicians
Community Service Related to Professional Work:
1990-2000 Member, National Alliance for the Mentally Ill (NAMI) 1993-1996 Professional Advisory Board, Epilepsy Association of Massachusetts 1994-1999 Board of Directors, American Suicide Foundation, Northeast Chapter 1995-1999 President, American Suicide Foundation, Northeast Chapter 2000-2002 Speaker, Community Speakers Bureau for American Foundation for Suicide Prevention 2001-2005 Speaker, Alzheimers Association Speakers Bureau 2001-2006 Member, Alzheimers Association, Education Committee 2002-2003 Member, Mayor’s Task Force on Mental Health and Aging 2006-2013 Member, Dept. of Mental Health Psychopharmacology Workgroup 2016- Mental Health Association in Delaware – Board Member 2016- Medical and Scientific Committee Member, Delaware Valley Chapter, Alzheimer’s Association
Editorial Boards and manuscript review:
1997-1998 Group for Advancement of Psychiatry, Publications Committee, member Ongoing American Psychiatric Press, Inc., ad hoc reviewer Ongoing Journal of Clinical Psychopharmacology, ad hoc reviewer Ongoing General Hospital Psychiatry, ad hoc reviewer Ongoing Psychiatric Services, ad hoc reviewer Ongoing The Medical Letter, ad hoc reviewer Ongoing Journal of Clinica l Psychiatry, ad hoc reviewer Ongoing Harvard Review of Psychiatry, ad hoc reviewer Ongoing American Journal of Geriatric Psychiatry, ad hoc reviewer Ongoing International Journal of Geriatric Psychiatry, ad hoc reviewer Ongoing Journal of the American Medical Association, ad hoc reviewer
Awards and Honors:
1977 Alpha Omega Alpha 1981-1983 Solomon Ginsburg Fellow, Group for the Advancement of Psychiatry 1983-1985 NIMH Junior Faculty Career Development Award 1990-2003 Fellow of the American Psychiatric Association 1996 Peer Recognition Award, Harvard Pilgrim Health Care 2000 Teacher of the Year Award, Cambridge Health Alliance Adult Psychiatry Residency Training Program 2000, 2002, 2005, 2007, 2009 Partners in Excellence Award, Partners Health Care 2004 American Psychiatric Association, Distinguished Fellow 2006 CINP-Lundbeck Neuroscience Foundation Prize for Education in Psychiatry and Neurology (to Curriculum Committee of ASCP for Model Psychopharmacology Curriculum Project) 2009-2015 Included in Boston Magazine’s “Top Doctor” listings 2010 American Association of Geriatric Society: Educator of the Year 2012 The Jonathan O. Cole Award (McLean Hospital) 2014 Massachusetts Psychiatric Society: Outstanding Psychiatrist Award for Advancement of the Profession 2015 Distinguished Life Fellow, American Psychiatric Association
Research, Teaching, and Clinical Contributions
A. Narrative Report of Research, Teaching, and Clinical Contributions My research focused first on aspects of emergency room psychiatry (diagnostic issues and the care of recidivists). Subsequently I explored risk management aspects of care (guidelines for care of suicidal patients; collaborative, consultative, and supervisory relationships) and issues in pharmacotherapy, especially of mood and anxiety disorders, with special interests in treatment resistance and in the interface areas between psychopharmacology and psychotherapy (such as the adjunctive role of medications in psychotherapy, new uses of psychopharmacologic agents, integration of treatment approaches, and issues in the training of physicians and non-physicians involved in the care of psychiatric patients). During the past decade, I have focused on areas in geriatric psychiatry, primarily related to depression in later life, dementia, Mild Cognitive Impairment, and Alzheimer’s Disease therapeutics. Clinically, I have contributed to the understanding of medication side effects including bradycardia/hypotension, bruxism, sexual dysfunction and discontinuation symptoms that accompany antidepressant treatment. As a geriatric psychiatrist, I have broadened public and professional awareness concerning mood symptoms in the cognitive intact and cognitively impaired geriatric populations. I speak to public interest groups and have lobbied for legislative reforms in the care of the elderly. I am an active teacher and supervisor of psychiatric residents, practicing psychiatrists, and psychiatric nurse clinical specialists. I have edited and/or contributed to books on collaborative treatment, pharmacotherapy, emergency psychiatry, anxiety disorders, neuropsychiatry, managed care and suicide, sexual dysfunction, and mood disorders. My most recent edited book, Mood Disorders in Later Life, was published in 2008.
B. Funding: PI for the following studies
1975 UCSF Medical Student Research Grant 1983-1985 NIMH Junior Faculty Career Development Award (Study on Recidivism Among Psychiatric Emergency Room Visitors) 2002 Harvard Center for Neurodegeneration and Repair ($10,000): The relationship between nutritional factors, mild cognitive impairment, and late life depression 2002 Cephalon Pharmaceuticals small grant for investigator initiated project (amount not finally determined): Modafanil in post-stroke apathy 2002 Glaxo Smith Kline small grant for investigator initiated project ($5,000): Late onset vs. early onset geriatric depression: Retrospective chart review of associated factors 2005 Memory Diagnostic Clinic Research Database 2005 BRL-049653/461: A double-blind, randomised, placebo-controlled, parallel-group study to investigate the effects of rosiglitazone (extended release tablets) on cerebral glucose utilisation and cognition in subjects with mild to moderate Alzheimer's Disease (AD) 2006 BRL-049653: An open-label extension to study 49653/461, to assess the long-term safety of rosiglitazone (extended release tablets) in subjects with mild to moderate Alzheimer's disease. 2008 ELN115727-301: A phase III, multicenter, randomized, double-blind, placebo-controlled, parallel group, efficacy and safety trial of bapineuzumab (AAB-001, ELN115727) in patients wi mild to moderate Alzheimer’s disease who are apolipoprotein E ε4 non- carriers. 2008 ELN115727-301: A phase III, multicenter, randomized, double-blind, placebo-controlled, parallel group, efficacy and safety trial of bapineuzumab (AAB-001, ELN115727) in patients wi mild to moderate Alzheimer’s disease who are apolipoprotein E ε4 carriers. 2008 A double-blind, randomized, parallel group, placebo-controlled sleep laboratory efficacy and safety study with Org 50081 in elderly subjects with chronic primary insomnia 2008 2-Week, Multicenter, Open Label Study to Evaluate the Effectiveness and Safety of donepezil hydrochloride (E2020) in subjects with mild to severe Alzheimer’s disease residing in an assisted living facility 2009 Effect of geriatric care management on caregivers and on demented patients residing at home 2009 Effect of LY2062430, an Anti-Amyloid Beta Monoclonal Antibody, on the Progression of Alzheimer’s Disease as Compared with Placebo 2012 Open label extension study of effect of LY2062430, an Anti-Amyloid Beta Monoclonal Antibody, on the Progression of Alzheimer’s Disease as Compared with Placebo 2016 Physician’s Professionalism Grant (Christiana Care Health System): “A Medical Home for Homeless Elders” 2016 IDEAS (Imaging Dementia – Evidence for Amyloid Scanning) – “Dementia Specialist” 2016 A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia (NAVIGATE-AD) – Site PI 2016 A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease – Site PI – pending IRB approval
C. Report of Current Research Activities
I oversaw and contributed to the Geriatric Psychiatry Research Program at McLean Hospital from 1999 through 2015 and my own active research projects at focused on immunotherapy of Alzheimer’s Disease as PI of several ongoing multi-center, industry-sponsored clinical trials. At CCHS, I am studying innovations in care models for patients with major neurocognitive disorders and bringing Alzheimer clinical trials to the Swank Memory Center.
D. Report of Teaching Activities
1. Local contributions a. Medical School Courses (Each teaching hour initially required approximately 5 hours of preparation time) Years Name of Course Teaching Role Student type and number, preparation and contact time 1982-1983 Mental Status Examination, in Physical Diagnosis Lecturer 30 Tufts second year medical Course students, 1 hour annual lecture 1982-1984 Emergency Psychiatry Lecturer 100 Tufts second year medical students, 1 hour annual lecture 1986- 2000 Psychopharmacology Case Studies, Lecturer 30 Tufts second year medical TUSM II Pharmacology Course students, 1 hour annual workshop/discussion group 2001-2004 Dementia in Depression, Depression in Dementia: A Lecturer 60 HMS second year medical Tale of Two Syndromes, in HST-350 Harvard Medical students, 1 hour annual School Pharmacology and Clinical Therapeutics lecture/discussion
b. Graduate Medical Courses (Each teaching hour initially required approximately 5 hours of preparation time) 1984 Recognition of Organic Mental Disorders, Simmons Lecturer 1 hr lecture to 30 social work First Year Social Work Psychopathology Seminar students 1984 Evaluation and Management of the Violent Patient, Lecturer 1 hr lecture to 15 psychiatry Beth Israel Hospital Psychiatry Consultation/Liaison residents, social work trainees, Service psychology trainees 1984-1987 PGII Psychopathology Course, Adult Psychiatry Lecturer Several 1 hour lectures each year to Residence Program, The Cambridge Hospital 8 psychiatry residents
1997 The Psychopharmacology of Violence, lecture for Lecturer 60 psychiatry residents Harvard Medical School “All Residents’ Day” conference 1998-2015 PGII and PGIII Psychopharmacology Courses in Occasional Invited Several 1 hour lectures annually to McLean/MGH Adult Psychiatry Residency Lecturer 12 psychiatry residents 2001-2015 PGII and PGIII Geropsychiatry Curriculum Coordinator and lectures, 1 annual lecture, several hours lecturer on mood and annually to organize curriculum anxiety disorders 2006-2015 PGI psychiatry resident lecture on late life mood Lecturer 2-3 residents, 1 hour per month disorders 2010-2015 Lecturer on multiple topics in Geriatric Psychiatry to 1 fellow, 10 hr/year Geriatric Psychiatry Fellow at McLean Hospital c. Selective List of Local Invited Teaching Presentations (1 hour presentations requiring 10 to 20 hours initial preparation, unless otherwise noted) 1984 Psychopharmacological Treatment of Borderline Grand Rounds lecturer 50 clinicians, mixed disciplines Personality Syndromes, Fuller Memorial Hospital 1984 Repeat Visitors to a Psychiatric Emergency Service, CME Course lecturer 50 clinicians, mixed disciplines Samaritans' Symposium on "The Enigma of Suicide" 1985 Advances in the Treatment of Schizophrenia, Alliance Lecturer 100 patients and family members for the Mentally Ill, Cambridge Chapter 1988 Evaluation and Management of the Patient with Lecturer Lecture given on 5 occasions at Treatment Resistant Depression DMH facilities to audiences of 50 to 100 mixed discipline clinicians as part of MMHC Extramural Lecture Series 1990 Pharmacotherapy of Personality Disorders, Beth Israel Grand Rounds Lecturer 40 mixed discipline clinicians Hospital Psychiatry Grand Rounds 1993 Depression and the Primary Care Physician. Medical Lecturer 20 medical residents Resident Rounds, Tufts School of Medicine 1993 Cosmedication: New Trends in Mood and Cognition Grand Rounds Lecturer 75 mixed discipline clinicians Enhancers. Grand Rounds in Psychiatry, The Mount Auburn Hospital 1993 Innovative Uses for Psychotropic Agents. Grand Grand Rounds Lecturer 35 mixed discipline clinicians Rounds, Newton Wellesley Hospital, Newton, MA 1994 Ethnopsychopharmacology and Primary Care Lecturer 30 psychiatrists Treatment of Depression. Greater Boston Chapter, Chinese American Medical Society 1995 Dealing with Anger and Guilt, Workshop for Discussion Leader 20 suicide survivors American Suicide Foundation New England Affiliate Conference for Suicide Survivors 1995 Psychopharmacology and Women, Grand Rounds, Grand Rounds Lecturer 30 mixed discipline clinicians Baystate Medical Center, Springfield, MA 1996 Antidepressants: The Third Generation, for Tri-City Lecturer 100 mixed discipline clinicians Mental Health and Retardation Center, Inc. 1996 Antidepressants and Sexual Function, Grand Rounds in Grand Rounds Lecturer 75 mixed discipline clinicians Psychiatry at the Boston VAH 1997 Sexual Function and Pharmacotherapy, Grand Rounds Lecturer 100 mixed discipline clinicians Psychopharmacology Grand Rounds at McLean Hospital 1997 Drug Interactions in Psychiatry and the P450 Enzyme Lecturer 50 mixed discipline clinicians System: A Managed Care Perspective. Co-presented with Mark Pollack, MD, as a CME lecture for Harvard Pilgrim Health Care. 1997 The Atypical Antipsychotics’ Place in Managed Care Lecturer 50 mixed discipline clinicians Delivery Systems. Co-presented with Ron Pies, MD, as a CME lecture for Harvard Pilgrim Health Care. 1997 Antidepressant Discontinuation Syndromes, Lecturer 30 nurse clinical specialists presentation to Choate Health Systems nurse clinical specialists 1998 Psychotropics’ Side Effects: An Overview of Lecturer 50 mixed discipline clinicians Mechanisms and Treatments, Tri-City Mental Health Center 2001 Update on Geriatric Psychiatry. McLean Hospital Panel Member 75 mixed discipline clinicians Grand Rounds (panelist) 2001 Pharmacotherapy of Late Life Depression. McLean Grand Rounds Lecturer 75 mixed discipline clinicians Hospital Psychopharmacology Grand Rounds 2001 Pharmacotherapy of Late Life Depression. Mt. Auburn Grand Rounds Lecturer 75 mixed discipline clinicians Hospital Psychopharmacology Grand Rounds, Cambridge, Massachusetts 2001 The Psychopharmacology of Sexual Desire. AASECT Lecturer 150 mixed discipline clinicians Annual Conference on Psychology and Alchemy of Erotic Desire. 2002 Treatment of Late Life Depression. Psychiatry Grand Grand Rounds Lecturer 50 mixed discipline clinicians Rounds, Bedford VA Hospital, Bedford, Massachusetts 2002 Depression in the Workplace: Consequences, Lecturer 60 businessmen and Detection, and Intervention. Young Presidents businesswomen Association, Boston, Massachusetts 2002 Mild Cognitive Impairment, in A Map Through the Lecturer 100 mixed discipline clinicians Maze, Alzheimer’s Association, Massachusetts Chapter, Marlborough, Massachusetts 2002 Mild Cognitive Impairment, for Greater Milford Lecturer 75 mixed discipline clinicians, Alzheimer’s Alliance caregivers, family members 2002 Late Life Depression, Psychiatry Grand Rounds Lecturer 75 mixed discipline clinicians Holy Family Hospital 2002 Late Life Depression, Psychiatry Grand Rounds Lecturer 60 clinicians from the Geriatric Bedford VA Hospital Medicine service 2002 Introduction to Alzheimers Disease, Lecturer 50 interdisciplinary clinicians, Brookline Council on Aging caregivers, family members 2002 Healthy Aging, Depression, and Memory Problems, Lecturer/Discussion 20 seniors and staff members Watertown Senior Center Leader 2002 Treatment of Late Life Depression, Psychiatry Grand Lecturer 25 staff members and psychiatry Rounds at Harvard South Shore Psychiatry Training residents Program, Brockton VA Hospital 2003 New Developments in Psychopharmacology for Adults Lecturer Usually 200 masters level social and the Elderly. Program developed for the NASW. workers. 2003 Management of Depression in Later Life, Grand Lecturer 30 staff members and trainees Rounds for Psychiatry Department, Tufts University School of Medicine and New England Medical Center 2004 Update on the Use of Memantine in AD – Presentation Lecturer 20 psychiatrists to MGH Consultation/Liaison Staff 2004 Aggressive Behaviors in Long Term Care: Lecturer 30 directors of assisted living Medical Aspects and Somatic Therapies – Presentation facilities to Mass*ALFA 2004 New Developments in the Management of Dementia – Lecturer 30 psychiatrists (residents and Grand Rounds at Brockton VA Hospital staff) 2005 Mild Cognitive Impairment for Lecturer 75 healthcare professionals Massachusetts Council on Aging 2006 Mild Cognitive Impairment for Lecturer 75 healthcare professionals Massachusetts Council on Aging 2007 Mild Cognitive Impairment for Lecturer 75 healthcare professionals Massachusetts Council on Aging (MCOA) 2007 Mild Cognitive Impairment for Lecturer 75 healthcare professionals and Massachusetts Assisted Living Facility Association long term care administrators (Mass ALFA) 2008 Mild Cognitive Impairment: Update and Clinical Lecturer 75 healthcare professionals and Recommendations long term care administrators Psychiatry Grand Rounds, Tufts University School of Medicine 2010 Mild Cognitive Impairment for Lecturer 75 healthcare professionals and Massachusetts Assisted Living Facility Association long term care administrators (Mass ALFA) 2010 Mild Cognitive Impairment for Lecturer 75 healthcare professionals Massachusetts Alzheimer’s Association 2011 Mild Cognitive Impairment for Lecturer 75 healthcare professionals and Massachusetts Assisted Living Facility Association long term care administrators (Mass ALFA) 2011 Supporting Optimal Cognitive Aging Lecturer 75 healthcare professionals (Mass Association of Older Americans) 2012 Mild Cognitive Impairment Lecturer 100 clinicians and healthcare (Alzheimer’s Association, Map Through The Maze) personnel 2016 Cognitive Assessment of Aging Physicians Lecturer 100 clinicians and healthcare Innovative Discoveries Lecture Series, personnel Christiana Care Health System 2016 The Spectrum of Mild Neurocognitive Disorders Lecturer 250 clinicians and healthcare Swank Symposium on Managing Dementia, personnel Christiana Care Health System 2016 Diabetes and Dementia: A Complicated Relationship Lecturer 200 clinicians and healthcare Innovative Discoveries Lecture Series, personnel Christiana Care Health System 2016 Geriatric Mental Health Crises Lecturer 50 law enforcement personnel DE Crisis Intervention Training (CIT) 2016 When Grief Goes Astray: Understanding Persistent Lecturer 40 attorneys specializing in estate Complex Bereavement Disorder planning and trusts d. Selective List of Continuing Medical Education Courses (1 hour presentations requiring 10 to 20 hours initial preparation, unless otherwise noted) 1990 A Strategy for the Pharmacotherapy of Personality Lecturer 200 pychiatrists Disorders, Mass. General Hospital Psychopharmacology Course 1990 User Friendly Psychiatry: Antidepressants in Primary Lecturer 50 pimary care physicians Care, Massachusetts Medical Society 1991 The Psychotherapist's Guide to Pharmacotherapy, Course Developer and 100 mixed discipline clinicians Cambridge Hospital CME eries Course (Organizer and Lecturer Instructor) 1991 Identifying Neurological Disorders in a Psychotherapy Course Developer and 100 mixed discipline clinicians Practice, The Cambridge Series (Organizer and Lecturer Instructor) 1991 Privatization of Mental Health Services in Course Developer, 200 mixed discipline clinicians Massachusetts: Opportunity forHealing? Presented Moderator, Lecturer under auspices of Heritage Hospital 1992 Psychopharmacology in the 90's: Critical Issues for Lecturer 3 hour workshop to 150 social Social Workers, Workshop presented under the workers auspices of the NASW 1991 A Strategy for the Pharmacotherapy of Personality Lecturer 100 psychiatrists Disorders, Tufts University School of Medicine Ninth Annual Psychopharmacology Update 1992 Obsessive Compulsive Disorders: Emerging Course Developer, 100 mixed discipline clinicians Perspectives, CME course presented under auspices of Moderator, and Lecturer TUSM Dept. of Continuing Medical Education 1992 Designer Personalities: Psychopharmacology for the Lecturer 100 psychiatrists Nineties, Tufts University School of Medicine Tenth Annual Psychopharmacology Update 1993 The Integration of Pharmacotherapy and Course Developer, 100 mixed discipline clinicians Psychotherapy in the Treatment of Moderator, and Lecturer Anxiety Disorders, CME Conference for The Cambridge Hospital 1993 Pharmacotherapy and the Changing Face of Psychiatric Lecturer 200 psychiatrists Practice: The Impact of Prescribing by Clinical Specialist Nurses. Massachusetts Psychiatric Association Annual Meeting 1993 Psychopharmacology in Depth for the Nonphysician Course Developer, Day-long (6 hours) presentation to Psychotherapist, CME course under auspices of The Moderator, and Lecturer 100 mixed discipline clinicians Training Institute of Atlanticare Hospital 1994 Update on Pharmacotherapy: What the Psychotherapist Lecturer 3 hour presentation to 150 social Needs to Know. workers 1994 Integrating Pharmacotherapy with Short-Term Lecturer 30 mixed discipline clinicians Psychotherapy, presented as staff CME exercise at Harvard Community Health Plan 1996 An Update on the Pharmacotherapy of Patients with Lecturer 200 mixed discipline clinicians Borderline Personality Disorder, in CME Course on Management of Borderline Patients in Crisis, a Symposium Presented by Taunton State Hospital and Massachusetts Mental Health Center 1996 Pharmacokinetics and the Cytochrome P450 Enzyme Lecturer 10 psychiatry residents System, psychiatry presentation for psychiatric residents and attendings at University Hospital, Boston Medical Center 1995 Psychopharmacology and Women, in "Women and Lecturer 100 mixed discipline clinicians Health", a Continuing Education Conference of The Cambridge Hospital and Harvard Medical School 1996 Sexual Function and Pharmacotherapy, in "Frontiers of Lecturer 100 mixed discipline clinicians Pharmacotherapy, a Continuing Medical Education conference of The Cambridge Hospital and Harvard Medical School 1996 Gender Differences in Psychopharmacology, in Gender Lecturer 50 mixed specialty physicians Issues in Health Care: Broadening Our Horizons. Massachusetts Medical Society 1996 Providing Effective Managed Care for the Suicidal Course Developer, 250 mixed discipline clinicians Patient, a conference jointly sponsored by the Moderator, and Lecturer American Suicide Foundation, Northeast Chapter, and Harvard Pilgrim Health Care 1997 Update on New Antipsychotic Agents, CME Program Lecturer 30 mixed discipline clinicians for Harvard Pilgrim Health Care 1998 Medicating the Violent Patient, in Adult Violence and Lecturer 100 mixed discipline clinicians Clinical Practice, a CME course offered in The Cambridge Series of The Cambridge Hospital 1998 Guidelines for Prescribing Psychiatrists in Lecturer 100 mixed discipline clinicians Consultative, Collaborative, and Supervisory Relationships. CME Program for Harvard Vanguard Medical Associates 1998 Treatment Resistant Depression and the Collaborative Lecturer 100 mixed discipline clinicians Treatment Relationship, for The Cambridge Hospital CME course entitled Psychodynamic Psychopharmacology 1999 Pharmacotherapy of Post-Traumatic Stress Disorder: Lecturer 200 mixed discipline clinicians Rationale, Review, and Recommendations, for The Massachusetts Mental Health Center CME course entitled Phase-Oriented Treatment of Psychological Trauma 1999 Risk Management and Chronically Suicidal Patients. Discussant of presented 50 mixed discipline clinicians HVMA Consensus Symposium, invited discussant of papers several papers 2000 Pharmacotherapy of PTSD: Current Approaches, Lecturer 100 mixed discipline clinicians Research, and Recommendations, in Adult Psychopharmacology: State-of-the-Art Therapies, McLean Hospital 2000 From the Hospital to the Nursing Home, in Dementia Lecturer 100 mixed discipline clinicians Update, CME program offered by McLean Hospital 2001 Pharmacotherapy of PTSD: Current Approaches, Lecturer 100 mixed discipline clinicians Research, and Recommendations, in Adult Psychopharmacology: State-of-the-Art Therapies, McLean Hospital 2001 Mild Cognitive Impairment, in CME Course on Lecturer 200 psychiatrists, neurologists, and Neurology/Psychiatry Interface, Closing the great primary care physicians Divide, CME Course Moderated by Bruce Price MD 2002 Suicide Risk and Psychiatric Pharmacotherapy, in Lecturer 300 mixed discipline clinicians Responding to Parasuicidal Behaviors, Suicide Threats, Suicide Attempts, and Suicide, a CME program jointly sponsored by the Office of Continuing Education and the Public Sector Division of the University of Massachusetts Medical School, Worcester, Massachusetts. 2002 Mood Disorders in Long Term Care, in Psychiatric Course Co-Director 200 mixed discipline clinicians Disorders in the Long-Term Care Setting, a CME Lecturer program sponsored by McLean Hospital 2002 Use of Two Antidepressants Together – When and Course Co-Director 200 psychiatrists When Not?, in Polypharmacy: Evidence Base vs. Lecturer Clinical Experience, a CME program provided by the Massachusetts Psychiatric Society 2003 Depression, Adherence, and the Doctor Patient Lecturer 200 mixed discipline clinicians Relationship, in The Practice of Psychotherapy, a CME program provided by the Cambridge Health Alliance and Harvard Medical School 2003 Mood Disorders in Long Term Care, in Psychiatric Course Co-Director 100 mixed discipline clinicians Disorders in the Long-Term Care Setting, a CME Lecturer program sponsored by McLean Hospital 2004 Advances in the Management of Dementia: Grand Lecturer 60 mixed disclipine clinicians Rounds at New England Rehabilitation Hospital 2004 Risk Management and Alzheimer’s Disease: 1 hour Lecturer 85 psychiatrists presentation in CME Course from MPS on Risk Management 2004 Diagnosis and Management of the Demented Patient: Course Director, 30 psychiatrists State of the Art and State of the Science Lecturer 2006 Cognitive Enhancers: How Worthwhile are They? For Lecture Developer, 100-140 healthcare providers per the MGH Psychiatry Academy Lecturer talk, 2006 Late Life Depression, Beth Israel Deaconess Medical Lecture Developer, 150-200 healthcare providers Center Review of Geriatric Medicine Lecturer 2007 Late Life Depression, for Lecture Developer, 100-140 healthcare providers per MGH Psychiatry Academy Lecturer talk, delivered in 5 different cities 2007 Late Life Depression, Beth Israel Deaconess Medical Lecture Developer, 150-200 healthcare providers Center Review of Geriatric Medicine Lecturer 2008 Late Life Depression, Beth Israel Deaconess Medical Lecture Developer, 150-200 healthcare providers Center Review of Geriatric Medicine Lecturer 2009 Late Life Depression, Beth Israel Deaconess Medical Lecture Developer, 150-200 healthcare providers Center Review of Geriatric Medicine Lecturer 2010 Late Life Depression, Beth Israel Deaconess Medical Lecture Developer, 150-200 healthcare providers Center Review of Geriatric Medicine Lecturer 2011 Late Life Mood Disorders, Beth Israel Deaconess Lecture Developer, 150-200 healthcare providers Medical Center Review of Geriatric Medicine Lecturer 2011 Ethical and Risk Management Aspects of Lecturer 150-200 psychiatrists Neuroenhancement: 1 hour presentation in CME Course from MPS on Risk Management 2011 Cognitive Enhancement: Grand Rounds at McLean Lecturer 100 healthcare providers Hospital 2011 Geriatric Mental Health Overview: An Invited Lecturer 25 psychologists “Teaching Day” at the Massachusetts School of Professional Psychology 2012 Late Life Depression, Beth Israel Deaconess Medical Lecture Developer, 150-200 healthcare providers Center Review of Geriatric Medicine Lecturer 2013 Late Life Depression, Beth Israel Deaconess Medical Lecture Developer, 150-200 healthcare providers Center Review of Geriatric Medicine Lecturer 2014 Late Life Depression, Beth Israel Deaconess Medical Lecture Developer, 150-200 healthcare providers Center Review of Geriatric Medicine Lecturer 2015 Late Life Depression, Beth Israel Deaconess Medical Lecture Developer, 150-200 healthcare providers Center Review of Geriatric Medicine Lecturer 2016 Late Life Depression, Beth Israel Deaconess Medical Lecture Developer, 150-200 healthcare providers Center Review of Geriatric Medicine Lecturer
e. Clinical Advisory/Supervisory Responsibilities Years performed Roles/Responsibilities Estimated Hours per Year 1982-1984 Attending Physician, Psychiatric Emergency Service, 1000 hours per year (plus on call availability at all times) New England Medical Center: took charge of teaching and supervising staff in emergency service 1984-2001 Supervising Psychiatrist, The Cambridge Hospital: 150 hours per year individual supervision of 2 to 3 psychiatry residents on weekly basis, group supervision of nurse clinical specialists 1991-1993 Supervising Psychiatrist, New England Medical 150 hours per year Center: Individual supervision of 2 to 3 psychiatry residents on weekly basis 1993-1999 Supervisor of 2 Nurse Clinical Specialists at Harvard 100 hours per year Pilgrim/ HVMA: Weekly individual meetings and review of clinical activity and documentation 1994 -1995 Pharmacotherapy and the Mental Health Clinical 50 hours per year Specialist. A continuing supervision group offered to the nursing and psychiatric staff of Choate Health Systems on weekly basis (6 to 8 RN CS, 1-2 MDs) with discussion of difficult cases and reading/discussion of pertinent literature 1995 Case Conference and Literature Seminar in 12 hours per year Pharmacotherapy for Nurse Clinical Specialists, Beverly Hospital: monthly group supervision for discussion of difficult cases and reading/discussion of pertinent literature (6 – 8 RN CS) 1995-2002 Psychopharmacology Case Conference, a monthly 12 hours per year clinical/supervisory seminar provided to psychiatry staff of Deaconess Waltham Hospital for discussion of difficult cases and reading/discussion of pertinent literature (4 - 6 RN CS, 4 – 5 MDs) 2004-2015 Supervisor for morning rounds (as needed on 6-12 hours per year occasional basis) for Clinical Evaluation Center at McLean f. Teaching Leadership Roles Years Title Special Accomplishments 1980-1982 Course Developer, MGH Neuropsychiatry Seminar for I developed a new educational opportunity for psychiatry Residents in Psychiatry residents who wanted to integrate teaching from behavioral neurology with psychiatry. A series of invited speakers discussed cases or topics of interest. 1980-1982 Medical student core seminar series, Instructor and co- I helped to develop the curriculum for Harvard Medical developer, MGH Psychiatry Department Students rotating through the MGH psychiatry department 1982-1984 Course developer and instructor, TUSM PGII Core I helped to plan and implement the core curriculum, as PGII Psychiatry Seminar preceptor, for the second year TUSM psychiatry residents 1982-1984 Course developer and instructor, TUSM PGII Summer I developed a “crash course” for new PGII TUSM residents to Seminar in Psychopharmacology and Emergency learn the skills that would improve their performance in crisis Psychiatry and on-call settings 1985-1990 Course organizer and instructor, PGII Seminar in I developed an integrated and progressive curriculum in basic Inpatient Psychopharmacology, The Cambridge and clinical aspects of psychopharmacology for the Cambridge Hospital Hospital adult psychiatry residency training program, 1985- 2000 Organizer and instructor, PGIII Course on beginning with case conferences in the PGI year, continuing Psychopharmacology in Outpatient Psychiatric with topics of interest to inpatient care in the PGII year, Therapy, The Cambridge Hospital progressing to special and outpatient topics in the PGIII year, and including outside speakers and resident presentations in the PGIV year. I taught all lectures in the PGI, II, and III years. Each course met on a weekly basis. 1985-1990 Organizer and intermittent instructor, PGIV Seminar on Advances in Psychopharmacology, The Cambridge Hospital 1990 Identifying Brain Disorders In A Psychotherapy I developed a curriculum for the BIP to introduce nonphysician Practice, Boston Institute for Psychotherapies (Course psychotherapists to the importance of considering and assessing Organizer and Instructor) for the presence of organic mental disorders in patients receiving psychotherapy services. This was an 8 week course meeting for 2 hours per week.
1992 Developer and instructor, PGIII Course on I developed and taught the PGIII psychiatry residents basic Psychopharmacology, New England Medical Center clinical psychopharmacology in a weekly seminar 2005 Developer, Lecturer in McLean Hospital Review of I developed this 2 day course with Dr. Donald Davidoff and Geriatric Psychiatry served as co-director and faculty member 2006 Developer, Lecturer in McLean Hospital Review of I developed this 2 day course with Dr. Donald Davidoff and Geriatric Psychiatry served as co-director and faculty member 2007 Developer, Lecturer in McLean Hospital Review of I developed this 2 day course with Dr. Donald Davidoff and Geriatric Psychiatry served as co-director and faculty member 2008 Developer, Lecturer in McLean Hospital Review of I developed this 2 day course with Dr. Donald Davidoff and Geriatric Psychiatry served as co-director and faculty member f. Advisees and trainees (In addition to teaching 15 years of PGII, III, and IV psychiatry residents in the Cambridge Hospital system and several years of residents elsewhere, I have continued to mentor and supervise several graduates, whose names are listed below)
1982-1984 Elizabeth Wharff LICSW I trained her in emergency psychiatry and mentored her developing career as a service director and supervisor. I encouraged her academic and writing pursuits and co-authored papers with her. She later co-directed the Psychiatric Emergency Service at Tufts University School of Medicine. 1984-1990 Eliot Gelwan MD He was the Medical Director, Pembroke Hospital. I mentored him as a resident and early career psychiatrist and encouraged his writing, teaching, and administrative work. 1984-1990 Pam Reeves MD She was the Director of Residency Training at Cambridge Health Alliance. I began supervising her when she was a resident and helped prepare her to run the CHA psychopharmacology program, which she did for several years prior to advancing to Director of Residency Training. I encouraged and helped in her teaching and publishing. 1995-1999 Frank Paolitto MD He is an established psychiatrist who used supervision with me to make a career transition into managed care outpatient work and he continued for some time to obtain supervision in psychopharmacology. 1993-1999 Patricia DeLuca RN CS She is a nurse clinical specialist who now works in managed care and private practice and whom I helped to develop prescribing skills. 1993- Diane Grimaldi RN CS She is a nurse clinical specialist who now works in private practice and whom I helped to develop prescribing skills. 1993- Ann Cousins RN CS She is a nurse clinical specialist who now works in private practice and whom I helped to develop prescribing skills. 1998-2002 Madeleine Albert MD She is an established psychiatrist, Lecturer in Psychiatry in the Cambridge Health Alliance system, staff member of the Zinberg Clinic and maintains a specialty interest in mental retardation. I supervised and mentored her development as an early career psychiatrist. 1998-2002 Anne Hallward MD She is a psychiatrist whose academic development I helped to support by inviting her to collaborate on a book and working closely with her to develop her writing skills. She does public sector outpatient clinic work and private practice in Maine. 2001-2002 Yusuf Sivrioglu MD He is a successful geriatric psychiatrist in Turkey who came to McLean Hospital to do research and writing with me for a year of study abroad and has since presented at the APA with me annually. 2004-2015 Brent Forester MD Dr. Forester is a rising academic and clinical psychiatrist whose career I have helped to develop in McLean Hospital’s geriatric psychiatry program. 2007-2009 Lynne Villemaire MD Dr. Villemaire, the geriatric program’s newest staff psychiatrist, worked with me on several clinical and writing projects 2011-2012 Gurprit Lamba MD Geriatric Psychiatry Fellow 2012-2013 Carolina Jimenez MD Geriatric Psychiatry Fellow 2013-2014 David Hsu MD Geriatric Psychiatry Fellow 2014-2015 Anothai Soonsawat MD Psychiatry Resident 2014-2015 Jennifer Gatchel MD PhD Geriatric Psychiatry Fellow and subsequent McLean Hospital staff psychiatrist
2. Regional, National, International Contributions Year Title, Organization, Type of Presentation 1985 The Role of the Lab in Diagnosing the "Difficult to Diagnose Patient", Jackson Brook Institute, Maine: 1 hour lecture on the use of laboratory methods in differential diagnosis of behavioral disorders 1990 Ethical Discourse in an Age of Science, American Psychiatric Association, Workshop at American Psychiatric Association Convention discussing new research I had carried out regarding psychiatrists’ approaches to common ethical dilemmas in clinical care 1997 Risk Management Guidelines in Split Treatment, in Psychopharmacology and Psychotherapy: Issues in Combined and Collaborative Treatment, University of Michigan Medical School: Invited lecturer in CME course 1998 Suicide Assessment and Treatment Planning, Dept. of Psychiatry, Buffalo General Hospital, 2 hour lecture presented under psychiatry department’s auspices in CME course
1999 Anticonvulsants in Psychiatry for Nurse Clinical Specialists, for the CME course entitled Beyond the Basics: Advanced Psychopharmacology for Nurses organized by a Connecticut group of RN CS clinicians in New Haven, CT, 1 hour lecture 1999 Update on Geriatric Psychopharmacology, for the McLean Hospital Psychopharmacology Update, Portland, Maine, 1 hour lecture 1999 Update on Bipolar Disorders, for the McLean Hospital Psychopharmacology Update, Portland, Maine, 1 hour lecture 2002 Late life depression, Department of Psychiatry, Danbury Hospital, Danbury, CT, Grand Rounds presentation 2002 As member of International Psychopharmacology Algorithm Project, Depression Committee, I reviewed and responded to a depression treatment algorithm prepared under the auspices of the Ministry of Health, Peoples Republic of China 2002 Late life depression, Department of Psychiatry, Stamford Hospital, Stamford, CT, Grand Rounds presentation 2003 Polypharmacy: Evidence Base vs. Clinical Experience, a symposium accepted for presentation at the 2003 American Psychiatric Association Annual Meeting, to be held in San Francisco, CA. The symposium was co-organized and will be moderated by and include a lecture by me. 2003 The Doctor-Patient Relationship in Psychopharmacology, a plenary session presented by invitation at a Canadian Psychiatric Association conference in Mont-Tremblant, Canada. 2003 The Massachusetts DMA/DMH Initiative, a symposium presented at the Institute on Psychiatric Services to be held in Boston, MA, 2003, co-organized and moderated by me. 2003 Pharmacotherapy of Cognitive and Noncognitive Symptoms of Alzheimer’s Disease, presented to the Boston Alzheimer’s Center 2003 Adherence and Alliance in the Pharmacotherapy of Depression, invited plenary for Canadian Psychiatric Association’s Annual Meeting, Halifax, Nova Scotia 2003 Depression in Later Life – CME Course (Course Director and lecturer) at American Psychiatric Association Annual Meeting, San Francisco, CA 2004 New Developments in the Management of Dementia (lecture) in Management of Complicated Dementia Patients, a symposium in The Academy of Psychosomatic Medicine’s 51st Annual Meeting 11/19/2004, Marco Island, FL 2004 Mood Disorders in Later Life – CME Course (Course Director and lecturer) at American Psychiatric Association Annual Meeting, New York, NY 2005 Mood Disorders in Later Life – CME Course (Course Director and lecturer) at American Psychiatric Association Annual Meeting, Atlanta, GA 2006 Mood Disorders in Later Life – CME Course (Course Director and lecturer) at American Psychiatric Association Annual Meeting, Toronto, Canada 2007 Nonmotor Aspects of Parkinson’s Disease – Invited lecture to NPACE, Cape Cod, MA (150 attendees) 2007 Mood and Anxiety Disorders in Later Life – CME Course (Course Director and lecturer) at American Psychiatric Association Annual Meeting, San Diego, CA 2007 Geriatric Psychiatry in 2007 (Comprehensive Review sponsored by McLean Hospital, 140 attendees), course director and lecturer, Boston, MA 2008 Clinical Strategies for Managing Comorbid Depression and Insomnia in the Elderly, in Emerging from the Anguish: Proximate Issues of Comorbid Insomnia and Late-Life Depression, Symposium at 20th Annual Meeting of American Association for Geriatric Psychaitry, Orlando, FL 2008 Innovative Treatment Models for Detecting and Dealing with Depression (in Linking Research to Practice: Advances in Care for Community-Based Elders, sponsored by Jewish Family & Children’s Service), Waltham, MA 2008 Mild Cognitive Impairment: Clinical and Research Update, Psychiatry Grand Rounds at Temple University,Philadelphia, PA 2008 Pharmacological Management of Mood and Behavior, in Dementia: A Comprehensive Update, a CME course of the Harvard Medical School/Partners Health Care 2009 Mood Disorders in Later Life – CME Course (Course Director and lecturer) at the American Psychiatric Association Annual Meeting, San Francisco, California 2009 Overview of Geriatric Psychopharmacology, in Psychopharmacology: A Master Class – CME Course (Directed by Dr. Carl Salzman) – Boston, MA 04/24/09 2009 Pharmacological Management of Mood and Behavior, in Dementia: A Comprehensive Update, a CME course of the Harvard Medical School/Partners Health Care, 06/04/09 2009 Mild Cognitive Impairment, Psychiatry Grand Rounds at Exeter Hospital, Exeter, New Hampshire 06/16/09 2009 Antidepressants in Geriatric Psychiatry, in Massachusetts Psychiatric Society 20th Annual Psychopharmacology Update 11/21/09, Waltham, MA 2009 Depression in the Elderly, in The Geriatric Toolbox, CME conference at Norfolk, VA, 12/12/09 2010 Mental Health and Mental Illness in Our Aging Population, 5 day course developed and directed for the "21st Annual Summer Seminars" series at Falmouth, Cape Cod 2010 Mood Disorders in Later Life – CME Course (Course Director and lecturer) at the American Psychiatric Association Annual Meeting, New Orleans, LA 2010 Non-Impaired Elders, Cognitive Enhancers, and the Boundaries of Usual and Customary Practice, a presentation within an APA NIDA Symposium entitled The Challenge of Cognitive Enhancers in Medicine, at the American Psychiatric Association Annual Meeting, New Orleans, LA 2010 The Geriatric Psychopharmacology Curriculum of the ASCP Model Curriculum, a presentation within an APA ASCP Symposium entitled The ASCP Model Psychopharmacology Curriculum, at the American Psychiatric Association Annual Meeting, New Orleans, LA 2011 Management of Apathy, Depression, and Sexual Inappropriate Behavior in Alzheimer’s Disease Patients, in Dementia: A Comprehensive Update, a CME course of the Harvard Medical School, 06/03/11 2011 Update on Treatment of Alzheimer’s Disease, a CME symposium at the AAGP, 2011 2011 Mood Disorders in Later Life – CME Course (Course Director and lecturer) at American Psychiatric Association Annual Meeting, New York, NY 2012 Mood Disorders in Later Life – CME Course (Course Director and lecturer) at the American Psychiatric Association Annual Meeting, Philadelphia, PA 2012 Prescribing Psychiatric Medications for Geriatric Patients: Pearls and Pitfalls – Workshop (faculty, discussant) at the American Psychiatric Association Annual Meeting, Philadelphia, PA 2012 The Spectrum of Mild Cognitive Impairment – invited lecture at Cape and Islands Psychiatric Society, Hyannis, Massachusetts 2013 Mood and Anxiety Disorders in Later Life, Invited Lecture, Las Vegas, Las Vegas Psychiatric Society Annual Psychopharmacology Review, Feb 16, 2013 2013 Prescribing Psychiatric Medications to Older Adults: Perils and Pearls, Invited Lecture, Las Vegas, Las Vegas Psychiatric Society Annual Psychopharmacology Review, Feb 16, 2013 2013 Depression in Later Life, Invited Lecture, American Association of Academic Psychiatry, Chicago, American Association of Academic Psychiatrists, April 4, 2013 2013 Advances in Biomarkers in Dementia, Invited Lecture, American Association of Academic Psychiatry, Chicago, American Association of Academic Psychiatrists, April 4, 2013 2013 Mood Disorders in Later Life – presented in American Association of Geriatric Psychiatry Board Review Course, Los Angeles, March 16, 2013 2013 Mood Disorders in Later Life – CME Course (Course Director and lecturer) at the American Psychiatric Association Annual Meeting, San Francisco, California, May 19, 2013 2013 Prescribing Psychiatric Medications for Geriatric Patients: Pearls and Pitfalls – Symposium (faculty, discussant) at the American Psychiatric Association Annual Meeting, San Francisco, California, May 19, 2013 2013 Management of Apathy, Depression, and Sexual Inappropriate Behavior in Alzheimer’s Disease Patients, in Dementia: A Comprehensive Update, a CME course of the Harvard Medical School, 05/31/2013 2013 Three Faces of Cognitive Enhancement – Invited Lecture at Sheppard Pratt, June 5, 2013 2013 Differential Diagnosis of Non-AD Dementias – Invited Lecture, First Kuwait North America Neurology Conference, Kuwait City, Kuwait, 4/26/2013 2013 The Spectrum of Minor Neurocognitive Disorders- Invited Lecture, First Kuwait North America Neurology Conference, Kuwait City, Kuwait, 4/26/2013 2014 Mood Disorders in Later Life – presented in American Association of Geriatric Psychiatry Board Review Course, Los Angeles, March 16, 2013 2014 Mood Disorders in Later Life – CME Course (Course Director and lecturer) at the American Psychiatric Association Annual Meeting, New York, NY, 5/04/14 2014 Management of Apathy, Depression, and Sexual Inappropriate Behavior in Alzheimer’s Disease Patients, in Dementia: A Comprehensive Update, a CME course of the Harvard Medical School, 05/30/2014 2014 Strategies for Optimal Cognitive Aging, Grand Rounds, McLean Hospital, 06/05/14 2014 Strategies for Optimal Cognitive Aging, Grand Rounds, Massachusetts General Hospital, 06/19/14 2015 Mood Disorders in Later Life – CME Course (Course Director and lecturer) at American Psychiatric Association Annual Meeting, Toronto, Canada, 05/16/15 2015 Mild Neurocognitive Disorders – CME Course (Course Director and lecturer) at American Psychiatric Association Annual Meeting, Toronto, Canada, 05/18/15 2015 Management of Apathy, Depression, and Sexual Inappropriate Behavior in Alzheimer’s Disease Patients, in Dementia: A Comprehensive Update, a CME course of the Harvard Medical School, 05/30/15 2015 Management of Noncognitive Behavioral Symptoms in Patients with Major Neurocognitive Disorders In Mass. General Hospital’s Primary Care Internal Medicine Update Course, CME course at HMS, 10/19/15 2016 Depression, Bereavement, and Suicide – Lecture in Board Review Course at American Association for Geriatric Psychiatry Annual Meeting, Washington DC, 03/17/16 2016 Mood Disorders in Later Life – CME Course (Course Director and lecturer) at the American Psychiatric Association Annual Meeting, Atlanta, GA, May 14, 2016 2016 Mild Neurocognitive Disorders – CME Course (Course Director and lecturer) at American Psychiatric Association Annual Meeting, Atlanta, GA, May 14, 2016 2016 Keynote speaker, Joseph Priestley Society luncheon, Chemical Heritage Society, Philadelphia, June 16, 2016- “A Guide To Optimal Cognitive Aging”, 50 members of the Chemical Heritage Society attending 2016 Major Neurocognitive Disorder: Best Practices and New Resources, Lewes, DE, October 1, 2016, 50 primary care clinicians attending 2016 Management of Noncognitive Behavioral Symptoms in Patients with Major Neurocognitive Disorders In Mass. General Hospital’s Primary Care Internal Medicine Update Course, CME course at HMS, 10/17/16 2016 The Spectrum of Mild Neurocognitive Disorders, in Sharing the Journey, Annual Delaware Dementia Conference 11/16/16, 115 attendees – caregivers, clinicians 2017 How Does Cognitive Aging Affect Physician Performance? Moderator and Discussant of Symposium presented at the American Association of Geriatric Psychiatry (March 25, 2017) and at the American Psychiatric Association Annual Meeting, May 24, 2017 2017 Depression, Bereavement, and Suicide – Lecture in Board Review Course at American Association for Geriatric Psychiatry Annual Meeting, Dallas, TX, March 24, 2017 2017 Mild Neurocognitive Disorders – CME Course (Course Director and lecturer) at American Psychiatric Association Annual Meeting, San Diego, CA, May 22, 2017 2017 Identifying and Helping Older Adults With Mild Neurocognitive Disorders – Symposium (Director, discussant) at American Psychiatric Association Annual Meeting, San Diego, CA, May 22, 2017
Bibliography:
Original Articles
1. Like R, Ellison J. Sleeping blood, tremor, and paralysis: a trans-cultural approach to an unusual conversion reaction. Culture, Medicine, and Psychiatry 1981;5:49-63.
2. Ellison J, Adler D. Psychopharmacologic approaches to borderline syndromes. Comprehensive Psychiatry 1984;25:255-262.
3. Ellison J, Wharff EA. More than a gateway: The role of the emergency psychiatry service in the community mental health network. Hospital and Community Psychiatry 1985;36:180-185.
4. Adler D, Drake R, Ellison J, and Carson D. Treatment of the nonpsychotic chronic patient: A problem of interactive fit. Am Journal of Orthopsychiatry 1987;57:579-586.
5. Ellison J, Barsky A, Blum NR. Frequent repeaters to an emergency service. Hospital and Community Psychiatry 1989;40:958-960.
6. Ellison J, Milofsky JE, Ely E. Fluoxetine-induced bradycardia and syncope in two patients. Journal of Clinical Psychiatry 1990;51:385-386.
7. Yonkers K, Ellison JM, Shera DM, et al. Pharmacotherapy observed in a large prospective longitudinal study on anxiety disorders. Psychopharmacology Bulletin 1992;28:131-137.
8. Oepen G, Levy M, Saemann R, et al. A neuropsychological perspective on dual diagnosis. Journal of Psychoactive Drugs 1993;25:129-133.
9. Ellison JM. Risk management recommendations for suicidal patients. Forum 1993;14:3-4.
10. Goldman HH, Adler DA, Berlant J, Docherty J, Dorwart R, Ellison JM, Pajer K, Siris S, Kapur S. The case for a services-based approach to payment for mental illness under national health care reform. Hospital and Community Psychiatry 1993;44:542-544.
11. Dorwart RA, Adler D, Berlant J, Dixon L, Docherty J, Ellison J, Goldman H, Sageman M, Siris S, Sonis WA. Outcomes assessment and psychiatric services. Hosp Community Psychiatry 1994;45:1165.
12. Adler DA, Pajer K, Ellison JM, et al: Schizophrenia and the life cycle. Community Mental Health Journal 1995;31;249-262.
13. Bisaillon DA, Ellison JM: CRICO's psychiatric care claims: A shift in risk. Forum 1995;16:11-12.
14. Yonkers KA, Ellison JM, Shera DM, et al. Description of antipanic therapy in a prospective longitudinal study. Journal of Clinical Psychopharmacology 1996;16:223-232.
15. Ellison JM, Sederer LI: Coordinating multiple providers of mental health treatment. Forum 1996;17:10-12.
16. Sederer LI, Ellison JM, Keyes C: Guidelines for prescribing psychiatrists in consultative, collaborative, and supervisory relationships. Psychiatric Services 1998;49:1197-1202 .
17. GAP Committee on Psychopathology: Confronting violence. Psychiatric Services 1998;49:865.
18. Ellison JM, Harney P: Treatment-resistant depression and the collaborative treatment relationship. Journal of Psychotherapy Practice and Research 2000;9:7-17.
19. Glick ID, Janowsky DS, Zisook S, Lydiard RB, Oesterheld JR, Ward NG, Ellison J, Halper J, Doraiswamy PM, Preven DW, Ross P, Klein DF: How should we teach psychopharmacology to residents? Results of the initial experience with the ASCP Model Curriculum. Academic Psychiatry 2001;25:90-7.
20. Ellison J: Teaching collaboration between pharmacotherapist and psychotherapist. Academic Psychiatry 2005;29:195-202.
21. Ellison JM, Harper DG, Berlow Y, Zeranski L. Beyond the ‘C’ in MCI: noncognitive symptoms in amnestic and nonamnestic mild cognitive impairment. CNS Spectrums 2008,13(1):66-72.
22. Ellison JM. Clinical Crossroads: A 60 year old woman with mild memory impairment. JAMA 2008;300(13):1566-1574.
23. Berlow YA, Wells WM, Ellison JM, et al: Neuropsychiatric correlates of white matter hyperintensities in Alzheimer's disease. Int J Geriatr Psychiatry. 2010;25(8):780-8.
24. Ujkaj M, Davidoff DA, Seiner SJ, Ellison JM, Harper DG, Forester BP. Safety and efficacy of electroconvulsive therapy for the treatment of agitation and aggression in patients with dementia. Am J Geriatr Psychiatry 2012;20(1):61-72.
25. Woodward MR, Harper DG, Stolyar A, Forester BP, Ellison JM. Dronabinol for the Treatment of Agitation and Aggressive Behavior in Acutely Hospitalized Severely Demented Patients with Noncognitive Behavioral Symptoms. Am J Geriatr Psychiatry 2014;22(4):415-9.
26. Jackson ML, Bex PJ, Ellison JM et al. Feasibility of a web-based survey of hallucinations and assessment of visual function in patients With Parkinson’s Disease. 2014 Jan 6;3(1):e1. doi: 10.2196/ijmr.2744.
27. Levy B, Celen-Demirtas S, Surguladze T, Eranio S, Ellison J. Neuropsychological screening as a standard of care during discharge from psychiatric hospitalization: the preliminary psychometrics of the CNS Screen. Psychiatry Res. 2014;215(3):790-6.
28. Weusten LH, Heijnen-Kohl SM, Ellison J, van Alphen SP.Interference of attention-deficit hyperactivity disorder in an older adult with a severe personality disorder and dermatillomania. Int Psychogeriatr. 2014 Feb;26(2):341-3.
29. Glick ID, Ellison JM. Improving the practice of clinical psychopharmacotherapy: the process of long- term management for patients and caregivers. J Clin Psychiatry 2015;76(6):735-6.
30. Rosowsky E, Young AS, Mallow MC, van Alphen SP, Ellison JM. A cross-validation to Delphi method approach to the diagnosis and treatment of personality disorders in older adults. Aging & Mental Health 2016 dx.doi.org/10.1080/13607863.2016.1261796
31. Ellison JM. The stage-dependent significance of SMC’s: Responding to the worried well…and to the unworried unwell. In Press, American Journal of Geriatric Psychiatry.
Clinical Communications
1. Ellison J, Dobies D. Methamphetamine abuse presenting as dysuria. Annals of Emergency Medicine 1984;13:198-200.
2. Rosenthal S, Ellison J. Propranolol withdrawal in psychosis [letter]. American Journal of Psychiatry 1990;147:534-5.
3. Ellison J, Gelwan E, Ogletree J. Complex partial seizure symptoms affected by marijuana abuse [letter]. Journal of Clinical Psychiatry 1990;51:439-440.
4. Ellison JM, Stanziani P. SSRI-associated nocturnal bruxism in four patients. Journal of Clinical Psychiatry 1993;54:432-434.
5. Ellison JM. SSRI withdrawal buzz [letter]. Journal of Clinical Psychiatry 1994;55:544-545
6. Gaufberg E, Ellison JM: Photosensitivity reaction to fluoxetine [letter]. Journal of Clinical Psychiatry 1995;56:486.
7. Ellison JM: Exercise-induced orgasms associated with fluoxetine treatment of depression. Journal of Clinical Psychiatry 1996;57:596-597.
8. Maltsberger JT, .Ellison J, Lovett CG: Robert Salter: Attempted suicide by jumping from a high bridge. Suicide and Life Threatening Behavior 1998;28:226-33.
9. Ellison JM, DeLuca P: Fluoxetine-induced genital anesthesia relieved by ginkgo biloba extract. Journal of Clinical Psychiatry 1998;59:199-200.
10. Ellison JM, Chu JA, Henry ME: Transient dissociative identity disorder after electroconvulsive therapy. Journal of ECT 2000;16:314-6.
Reviews and Educationally Relevant Publications
1. Ellison J. Alterations of sexual behavior in temporal lobe epilepsy. Psychosomatics 1982;23:499-509.
2. Ellison J. DSM-III and the diagnosis of organic mental disorders. Annals of Emergency Medicine 1984;13:521-528.
3. Ellison J. Emergency treatment of acute psychosis, agitation, and anxiety. Hospital and Community Psychiatry 1985;36:351-352.
4. Ellison J, Blum NR. Repeat visitors in the psychiatric emergency service: A critical review of the data. Hospital and Community Psychiatry 1986;37:37-41.
5. Ellison J, Jacobs D. Emergency psychopharmacology: A review and update. Annals of Emergency Medicine 1986;15:962-968.
6. Ellison J, Hughes D, White K. An emergency psychiatry update. Hospital and Community Psychiatry 1989;40:250-260.
7. Ellison JM: SSRIs and sexual dysfunction. Psychiatric Times 1998;XV(8):28-34.
8. Ellison JM: Antidepressant-induced sexual dysfunction: Review, classification, and treatment suggestions. Harvard Review of Psychiatry 1998;6:177-189. 9. Ellison JM, Sivrioglu Y: Antidepressant treatment of geriatric depression: the evidence base and state of the art. International Drug Therapies Newsletter 2003;38(2):9-16.
10. Sivrioglu EY, Berlow YA, Ellison JM: Recognition and management of late-life depression. Primary Psychiatry 2004;11:41-7.
11. Forester BP, Antognini F, Sivrioglu EY, Schoos R, Fish DW, Ellison JM: Geriatric mania. Directions in Psychiatry 2004;24:43-60.
12. Lamba G, Ellison JM. Reducing clozapine-induced hypersalivation. Current Psychiatry 2011;10:77-8.
13. Ellison JM, Kyomen HH, Harper DG. Depression in later life: an overview with treatment recommendations. Psychiatr Clin N Am 2012;35:203-229.
14. Ellison J, Forester B. Introduction (to special edited issue on Geriatric Psychiatry). Harv Rev Psychiatry. 2015 Sep-Oct;23(5):301-3.
15. Ellison JM, Macklin K. Alzheimer’s disease: Our evolving view, our new interventions. Delaware Journal of Public Health 2016;2(5):28-31.
Books and Monographs: Author 1. Hallward A, Ellison JM: Antidepressants and Sexual Function. London: Harcourt Brace Medical Publications, 2001.
Corporate Author
1. Group for the Advancement of Psychiatry, Committee on Psychopathology, The Positive Aspects of Long Term Hospitalization in the Public Sector for Chronic Psychiatric Patients. New York: Mental Health Materials Center, 1982.
2. Group for the Advancement of Psychiatry, Committee on Psychopathology, Interactive Fit: A Guide to Nonpsychotic Chronic Patients. New York: Brunner/Mazel, 1987.
3. Group for the Advancement of Psychiatry, Committee on Psychopathology, Beyond Symptom Suppression: A Guide to the Treatment of Schizophrenia. Washington, D.C.: American Psychiatric Press, Inc., 1991.
Editor, Compiler, Major Contributor
1. Ellison JM (ed): The Psychotherapist's Guide to Pharmacotherapy. Chicago: Year Book Medical Publishers, 1989.
2. Ellison JM, Weinstein C, Hodel-Malinofsky T (eds): The Psychotherapist's Guide to Neuropsychiatry. Washington, D.C: American Psychiatric Press, Inc., 1994.
3. Ellison JM (ed): Integrative Treatment of Anxiety Disorders. Washington, D.C: American Psychiatric Press, Inc., 1996.
4. Ellison JM (ed): Treating the Suicidal Patient in Managed Care. Washington, D.C. American Psychiatric Press, Inc., 2001.
5. Ellison JM, Verma S (eds): Depression in Later Life. New York, New York. Marcel Dekker, Inc., 2003.
6. Ellison JM, Kyomen H, Verma S (eds): Mood Disorders in Later Life (2nd Edition). New York, New York. Informa 2008.
Chapter in Book
1. Primm S, Falk WE, Grimaldi D, Kielhofner N, Smith JM, Ellison JM. Fundamentals of combined treatment. In: Ellison JM, ed. The Psychotherapist's Guide to Pharmacotherapy. Chicago: Year Book Medical Publishers, 1989:3-21.
2. Ellison JM, Smith J. Intertherapist conflict in combined treatment. In: Ellison JM, ed. The Psychotherapist's Guide to Pharmacotherapy. Chicago: Year Book Medical Publishers, 1989:96-115.
3. Ellison JM. Medications for mental disorders: A brief history and an overview of current uses. In: Ellison JM, ed. The Psychotherapist's Guide to Pharmacotherapy. Chicago: Year Book Medical Publishers, 1989:119-143.
4. Ellison JM. An introduction to psychiatric medications. In: Ellison JM, ed. The Psychotherapist's Guide to Pharmacotherapy. Chicago: Year Book Medical Publishers, 1989:144-190.
5. Johnson ML, Ellison JM. Interactions of alcohol, street drugs, and prescribed medications. In: Ellison JM, ed. The Psychotherapist's Guide to Pharmacotherapy. Chicago: Year Book Medical Publishers, 1989:240-256.
6. Marlink P, Ellison JM. Use of the laboratory in pharmacotherapy. In: Ellison JM, ed. The Psychotherapist's Guide to Pharmacotherapy. Chicago: Year Book Medical Publishers, 1989:289-294.
7. Ellison JM. Emergency treatment of acute psychosis, agitation, and anxiety. In: Mezzich JE, Zimmer B, eds. Emergency Psychiatry. Madison, Connecticut: International Universities Press, Inc., 1990:137-141.
8. Ellison J, Adler DA. A strategy for the pharmacotherapy of personality disorders. In: Adler DM, ed. Treating Personality Disorders. San Francisco: Jossey-Bass Inc., 1990:43-64.
9. Fiester SJ, Ellison JM, Docherty JP, Shea T. Comorbidity of personality disorders: Two for the price of three. In: Adler DM, ed. Treating Personality Disorders. San Francisco: Jossey-Bass Inc., 1990:103-114.
10. Ellison JM, Shader R. The pharmacologic treatment of personality disorders: A dimensional approach. In: Shader R, ed. Manual of Psychiatric Therapeutics, 2nd Edition, Boston: Little, Brown, and Co., 1993:259-274.
11. Ellison JM, Stanziani P. Temporal lobe epilepsy: Its relevance to the psychotherapist. In: Ellison JM, Weinstein C, Hodel-Malinofsky T, eds. The Psychotherapist's Guide to Neuropsychiatry. Washington, D.C.: American Psychiatric Press, Inc., 1994:303-328.
12. Ellison JM, Pfaelzer C: Emergency pharmacotherapy: The evolving role of medications in the emergency department. In: Allen MH, ed. The Growth and Specialization of Emergency Psychiatry. San Francisco: Jossey-Bass Publishers, 1995: 87-98.
13. Popp S, Ellison JM, Reeves P: Neuropsychiatry of the anxiety disorders. In: Ellison JM, Weinstein C, Hodel-Malinofsky T, eds. The Psychotherapist's Guide to Neuropsychiatry. Washington, D.C.: American Psychiatric Press, Inc., 1994:369-408.
14. Yonkers KA, Ellison JM. Anxiety disorders and their pharmacological treatment. In: Jensvold MF, Halbreich U, Hamilton J, ed. Psychopharmacology of Women: Sex, Gender and Hormones. Washington, D.C.: American Psychiatric Press, Inc., 1996:261-286.
15. Pfaelzer C, Ellison JM, Popp S. Panic Disorder: Panic disorder: Pharmacotherapy in integrative treatment. In: Ellison J, ed. Integrative Treatment of Anxiety Disorders. Washington, D.C., American Psychiatric Press, Inc., 1996:53-76.
16. Reeves P, Ellison JM: Posttraumatic stress disorder: A collaborative and integrative approach to pharmacotherapy. In: Ellison J, ed. Integrative Treatment of Anxiety Disorders. Washington, D.C., American Psychiatric Press, Inc., 1996:135-152.
17. Sherman A, Ellison JM, Iwamoto S: Obsessive-compulsive disorder: Integration of cognitive-behavior therapy with pharmacotherapy. In: Ellison J, ed. Integrative Treatment of Anxiety Disorders. Washington, D.C., American Psychiatric Press, Inc., 1996:153-197.
18. Dorwart RA, Adler D, Berlant J, Dixon LB, Docherty J, Ellison J, Goldman HH, Sageman M, Siris S: Outcomes management strategies in mental health: Application and implications for clinical practice. In: Sederer LI, Dickey B, eds. Outcomes Assessment in Clinical Practice. New York, Williams & Wilkins, 1996: 45-54.
19. Harney PA, Ellison JM: Panic and obsessive-compulsive disorders. In: Sederer LI, Rothschild AJ, eds: Acute Care Psychiatry: Diagnosis and Treatment. Baltimore, Williams & Wilkins, 1997: 123-140.
20. Ellison JM: Enhancing adherence in the pharmacotherapy treatment relationship. In: Tasman A, Riba MB, Silk KR (eds): The Doctor-Patient Relationship in Pharmacotherapy. Washington, DC, American Psychiatric Press, Inc., 2000, pp. 71-94.
21. Ellison JM: Psychiatric pharmacotherapy, suicide, and managed care. In: Ellison JM (ed): Treating the Suicidal Patient in Managed Care. Washington, DC, American Psychiatric Press, Inc., 2001.
22. Ellison JM, Gottlieb G: Recognition and management of late life mood disorders. In: Sirven JI, Malamut BL (eds): Clinical Neurology of the Older Adult. Philadelphia, Lippincott Williams & Wilkins, 2002, pp. 447-462.
23. Ellison JM, McCarter RHG: Chapter 8: Combined treatment for anxiety disorders. In: Stein DJ, Hollander E (eds): The American Psychiatric Textbook of Anxiety Disorders. Washington, DC, American Psychiatric Press, Inc., 2002, pp. 93-106.
24. Ellison JM, Verma SK, Sivrioglu Y: Pharmacotherapy of late life depression: Review and recommendations. In Ellison JM, Verma SK (eds): Depression in Later Life. New York, New York. Marcel Dekker, Inc., 2003, pp. 193-224.
25. Ellison JM, Shader R. The pharmacologic treatment of personality disorders: A dimensional approach. In: Shader R, ed. Manual of Psychiatric Therapeutics, 3rd Edition, Boston: Little, Brown, and Co., 2003, pp. 169-183.
26. Ellison JM, Shader R. The pharmacologic treatment of personality disorders: A dimensional approach. In: Shader R, ed. Manual of Psychiatric Therapeutics, 4th Edition, Boston: Little, Brown, and Co., in press.
27. Ellison JM, Gottlieb G: Recognition and management of late life mood disorders. In: Sirven JI, Malamut BL (eds): Clinical Neurology of the Older Adult, 2nd Edition. Philadelphia, Lippincott Williams & Wilkins, 2008.
28. Ellison JM, Sivrioglu EY. Salzman C: Pharmacotherapy of late-life depression: Evidence-based recommendations. In Ellison JM, Kyomen HH, Verma SK (eds): Mood Disorders in Later Life (Second Edition). New York, New York. Informa Healthcare, 2008, pp. 239-290.
29. Ellison JM, Ujkaj M. Recognition and treatment of late-life depression. In Schwartz TL, Petersen TJ (eds): Depression. Treatment Strategies and Management. Second Edition. Informa Healthcare, 2009, pp 248-255.
30. Ellison JM, Greywolf CT. Management of depression, apathy, and sexualized inappropriate behavior in dementia. In Dickerson BC, Atri A (eds): Dementia: Comprehensive Principles and Practice. New York,. Oxford University Press, 2014, pp. 588-599.
31. Fenn HH, Ellison JM, and Yessengaliyeva E. Chapter 17: Acute Inpatient Psychiatric Settings. In Hategan A, Bourgeois JJ. On Call Geriatric Psychiatry – Springer, 2016, pp. 231-249.
Newsletter
The Consultant: A Psychopharmacology Newsletter for Psychotherapists, A bimonthly newsletter, founded and edited by Ellison JM, for 2 years (1985-7)
Book Reviews
1. Ellison J. Book Review of Perry PJ, Alexander B, Liskow BI: Psychotropic Drug Handbook (3rd Ed). Harvey Whitney Books, Cincinnatti, 1981, in Journal of Clinical Psychopharmacology, 1982.
2. Ellison J. Book Review of Garfinkel, ed. The Role of Drug Treatments for Eating Disorders. General Hospital Psychiatry 1988;10:226-228.
3. Ellison J: Book Review of Tupin JP, Shader RI, Harnett DS, eds. Handbook of Clinical Psychopharmacology. Aronson, New Jersey, 1988, in Hospital and Community Psychiatry 1989;40:539.
4. Ellison J: Book Review of Flach F, ed. Psychobiology and Psychopharmacology. Directions in Psychiatry Monograph No. 2. New York, Norton, 1988, in Hospital and Community Psychiatry 1989;40:969.
5. Ellison J: Book Review of Mezzich J, Zimmer B, eds. Emergency Psychiatry. International Universities Press, Inc., Madison, Connecticut, 1990; and Hillard JR, ed. Manual of Clinical Emergency Psychiatry, American Psychiatric Press, Inc., Washington, D.C., 1990. Hospital and Community Psychiatry June, 1990.
6. Ellison J: Book Review of Gorman J, The Essential Guide to Psychiatric Drugs. St. Martin's Press, New York, 1990, Hospital and Community Psychiatry 1991;42:542-3.
7. Ellison J: Bitter pills for biopsychiatrists (review of Toxic Psychiatry by Peter R. Breggin). Technology Review October 1991;77-79.
8. Ellison J: Book Review of Meltzer HY (ed), Novel Antipsychotic Drugs. Raven Press, New York, 1992, Hospital and Community Psychiatry 1993;44:397.
9. Ellison J: Book Review of Sledge WH, Tasman A (eds), Clinical Challenges in Psychiatry. American Psychiatric Press, Inc., Washington, D.C., 1993. Hospital and Community Psychiatry 1994;45:282.
10. Ellison J: Book Review of Stone MH, Abnormalities of Personality: Within and Beyond the Realm of Treatment. W.W. Norton & Company, New York, 1993, 546 pp. Journal of Clinical Psychopharmacology 1994;14:294-5.
11. Ellison J: Book Review of Preston J, O'Neal J, Talaga MC, Handbook of Clinical Psychopharmacology for Therapists. New Harbinger Publications, Inc., Oakland, CA, 1994, 241 pp. Journal of Clinical Psychopharmacology 1995;15:234-5.
12. Ellison J: Book Review of Mellow AM, Geriatric Psychiatry. American Psychiatric Press, Inc., Washington, DC, 2003, 212 pp. Psychiatric Services 2004;55:328.
13. Ellison J: Book Review of Salzman C (ed), Clinical Geriatric Psychopharmacology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA, 2004, 800 pp. J Clin Psychiatry 2005;66:805-6.
14. Ellison J: Book Review of Depp CA, Jeste MD: Successful Cognitive and Emotional Aging. American Psychiatric Press, Inc., Washington D.C., 2010, 419 pp. J Clin Psychiatry 2011;72:726-7.
15. Ellison J: Book Review of Summergrad P et al. Integrated Care in Psychiatry: Redefining the Role of Mental Health Professionals in the Medical Setting. J Clin Psychiatry 2016;77(2):e172.
Abstracts
1. Ujkaj M, Forester BP, Seiner SJ, Harper D, Davidoff DA, Ellison JM. Safety and efficacy of electroconvulsive therapy (ECT) for the treatment of agitation and other behavioral complications of dementia. Presented at AAGP Annual Meeting, Orlando, Fl 3/16/2008. EI Poster Number 53, AJGP 2008;16(3)[suppl 1]:pA72.
Nonprint Materials
1. Sederer L, Ellison JM, Fyfe A: Guidelines for Psychiatrists Providing Consultation, Collaboration, & Supervision. American College of Psychiatrists Psychiatric Update (discussant on nationally distributed audiotape, 1998)
2. Ward NG, Ellison JM, Lydiard RB: Treatment Resistant Depression. Slide set distributed by American Society of Clinical Psychopharmacology as component of its Model Psychopharmacology Curriculum (2002).
3. Ellison JM, Ketter T, Kosten TR, et al: Psychopharmacology in the Emergency Room. Slide set distributed by American Society of Clinical Psychopharmacology as component of its Model Psychopharmacology Curriculum (2002).
4. Segraves T, Ellison JM, Lydiard RB: Sexual Dysfunction Caused by Depression and Antidepressants. Slide set distributed by American Society of Clinical Psychopharmacology as component of its Model Psychopharmacology Curriculum (2002).
5. Ward NG, Ellison JM, Lydiard RB: Antidepressants: Basics. Slide set distributed by American Society of Clinical Psychopharmacology as component of its Model Psychopharmacology Curriculum (2002).
6. Ellison JM: Evidence Based Medicine and Psychiatry. Slide set distributed by American Society of Clinical Psychopharmacology as component of its Model Psychopharmacology Curriculum (2003, revised 2007 and 2010).
7. Ellison JM: The Doctor-Patient Relationship in Psychiatric Pharmacotherapy. Slide set distributed by American Society of Clinical Psychopharmacology as component of its Model Psychopharmacology Curriculum (2003, revised 2007 and 2010).
8. Ellison JM: Geriatric Depression: Prevalence and Assessment. Slide set distributed by American College of Neuropsychopharmacology (2003, revised 2007 and 2010).
9. Ellison JM: Evidence Based Medicine in mental health Slide set distributed by American Society of Clinical Psychopharmacology as component of its Model Psychopharmacology Curriculum 4th Edition (2007).
10. Ellison JM: The therapeutic alliance and adherence in the treatment of depression. Slide set distributed by American Society of Clinical Psychopharmacology as component of its Model Psychopharmacology Curriculum 4th Edition (2007).
11.Small GW, Ellison JM: Dementia. Slide set distributed by American Society of Clinical Psychopharmacology as component of its Model Psychopharmacology Curriculum 4th Edition (2007).
12. Small GW: Depression in later life: epidemiology, assessment, and treatment. Slide set distributed by American Society of Clinical Psychopharmacology as component of its Model Psychopharmacology Curriculum 4th Edition (2007, revised 2010).